Navigation Links
Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
Date:6/2/2008

uch forward looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the clinical trials of Jazz Pharmaceuticals' JZP-6 product candidate, including the risk that clinical trial results may require Jazz Pharmaceuticals to discontinue its development, and risks related to our reliance on third parties to conduct the clinical trials for our product candidates. These and other risk factors are discussed under "Risk Factors" in the Quarterly Report on Form 10-Q for the quarter ended March 31, 2008 filed by Jazz Pharmaceuticals with the Securities and Exchange Commission on May 15, 2008. Jazz Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
2. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
3. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
4. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
5. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
6. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
7. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
8. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
9. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
10. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
11. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , Sept. 4, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-nine. ... the Company, commented, "We believe our current pipeline of ...
(Date:9/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/gvzjt8/investigation ) has ... Sodium Ibandronate Market, 2010-2019" report to their offering. ... trade name of Bondronat in Germany ... was approved by the FDA to come into the market ... of Boniva. However, since drug makers later developed more convenient ...
(Date:9/4/2015)... MENLO PARK, Calif. , Sept. 4, ... ("DelMar" and the "Company"), a biopharmaceutical company focused on ... announced its financial results for the fiscal year ending ... Company highlights and expected near-term milestones. ... call and live webcast for investors, analysts and other ...
Breaking Medicine Technology:IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2Investigation Report on China's Sodium Ibandronate Market 2010-2019 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8
... DIEGO, Jan. 9, 2012   Aethlon Medical, Inc. ... to address infectious disease and cancer, announced that an ... CEO, James A. Joyce, at the Biotech Showcase™ 2012, ... (Photo:  http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b ) ...
... or the Company) (NASDAQ: HOLX ), a ... medical imaging systems and surgical products dedicated to serving ... Inc.,s (Conceptus) request for an injunction barring future sales ... denied and that no royalty will be due to ...
Cached Medicine Technology:Aethlon Medical Discloses Availability of the Biotech Showcase™ 2012 Presentation 2Hologic Announces Denial of Conceptus' Request for Injunction in Patent Infringement Suit 2Hologic Announces Denial of Conceptus' Request for Injunction in Patent Infringement Suit 3
(Date:9/4/2015)... , ... September 04, 2015 , ... Many consumers are looking for a quick and ... their solution. , The patent-pending K Med Cups provide a quick and simple way to ... relieve a cold, flu or cough. As a result, they enhance comfort and health. The ...
(Date:9/4/2015)... ... September 04, 2015 , ... Having access to a doctor can sometimes ... increasing amount of unnecessary emergency room visits which affects hospitals’ abilities to provide quality ... bill. Fortunately, a solution to alleviate this problem has recently presented itself, the new ...
(Date:9/4/2015)... ... 04, 2015 , ... Compliance officers deal with many high-risk ... physician self-referral law. “Stark Law DOs and DON’Ts: Best Practices for Your ... (AIS), will detail which deals are attracting the most government scrutiny and what ...
(Date:9/4/2015)... ... 2015 , ... Friday night, Chicago lovebirds Jenny McCarthy and Donnie Wahlberg celebrated ... event supporting families affected by autism, raising nearly $250,000. , 150 guests, including ... the Oscar Swan Inn to support the cause. , McCarthy tugged the heartstrings ...
(Date:9/3/2015)... CA (PRWEB) , ... September 03, 2015 , ... TransPack ... X. Users can choose from wipes and framing transitions in 30 different styles. ... made exclusively for Final Cut Pro X. , TransPack Toon features 90 cartoon transitions ...
Breaking Medicine News(10 mins):Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2
... lower the level of proof needed for a medic to ... Sir Liam Donaldson. ,Following the inquiry into GP ... weighted in favor of doctors and therefore proposed his plans ... include regular MoT-style checks on medics' abilities. The plans have ...
... announced the launch of a computer game targeted at ... to combat diseases like AIDS.// ,Announced this ... Swahili versions at unicef.org/voy/explore /aids/explore_1360.html, ,Unicef called it ... game that empowers young people to make good life ...
... in the lungs and airways of people with cystic fibrosis. ... in determining how the disease progresses. The proteins were uncovered ... thought to play a role in the body's immune system. ... the immune system's role in cystic fibrosis, a genetic disease ...
... of alcohol abuse can only be tackled by more action ... health minister// voiced support for higher taxes on drinks. ... Health Action on Alcohol Problems (SHAAP) to raise awareness of ... misuse. ,However the SNP and Conservative parties say ...
... the risk of colorectal cancer in laboratory mice which suggested ... cancer in humans, according to a study by Canadian researchers. ... study of 137 mice, saw that animals that were fed ... of developing colorectal cancer than rodents which were given a ...
... high-level meeting, Prime Minister Manmohan Singh Thursday reviewed the ... dengue and called for setting up an early warning ... over 160 people have died this year due to ... of chikungunya, Health Minister Anbumani Ramadoss has disclaimed any ...
Cached Medicine News:Health News:Doctors Protest against Regulation Changes 2Health News:Now A Computer Game To Battle AIDS 2Health News:Proteins in lungs of patients with cystic fibrosis 2Health News:Proteins in lungs of patients with cystic fibrosis 3Health News:Alcohol Abuse Must be solved with Action 2Health News:Colon cancer Linked to low-folate diet 2Health News:Colon cancer Linked to low-folate diet 3
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTC/1Q chairs are recommended for the ... room, static control, health care and ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With cast ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
Medicine Products: